On November 30, 2023, BrightPath Biotherapeutics Co., Ltd. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
59 JPY | 0.00% | +5.36% | -32.18% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
186.4 AUD | -0.61% | +1.68% | 44.31B | ||
59 JPY | 0.00% | +5.36% | 26.51M | ||
1st Jan change | Capi. | |
---|---|---|
-32.18% | 26.51M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 4594 Stock
- News BrightPath Biotherapeutics Co., Ltd.
- BrightPath Biotherapeutics Co., Ltd. announced that it has received ¥5.1678 million in funding from Macquarie Group Limited